Orthomed Partners with Osso VR, Bringing First-of-its-Kind VR Training to Veterinary Care

Orthomed, a member of the Infiniti Medical family, announces today a partnership with Osso VR, the leading virtual reality-based surgical training company, officially bringing RoVR™ surgical training to the animal health market. This first-of-its-kind training technology allows for veterinarians to practice procedures anytime, anywhere in VR. The goal of this partnership is for Orthomed and its parent company, Infiniti Medical, to offer a full content library of veterinary procedures using Osso VR’s technology.

Already widely adopted in the medical industry, Osso VR’s on-demand, educational experiences are effective, repeatable, and measurable to help veterinarians reach proficiency with emerging techniques and medical devices. Utilizing this technology, veterinarians will have access to VR training to gain muscle memory for increasing performance, knowledge and confidence in various procedures. Allowing veterinarians to experience and practice a procedure in VR before performing it on an animal increases the chances for a positive outcome.

“RoVR™ is a valuable new resource for veterinarians to gain exposure and practice in performing surgeries. There is a growing body of evidence which shows that repeated  participation in VR training leads to increased confidence and more effective clinical outcomes for our pets,” said Jared Finegold, CEO of Infiniti Medical-Orthomed. “We are proud to be the first animal health company offering VR training technology to veterinarians worldwide.”

The first VR module being released is for cruciate ligament repair surgery using OrthoMed’s Canine Cruciate Repair System. The surgery is a common and mainstream canine procedure that occurs when the dog has a tear in their cruciate ligaments, located in the knee. The surgery provides re-stabilization of the knee to help them regain their mobility.

“Osso VR offers the opportunity to train and assess yourself on any procedure in VR  in order to learn new procedures, and to maintain your proficiency on existing ones.  I’m incredibly excited that we can expand our evidence-backed technology into veterinary care for the first time ever by partnering with Infiniti Medical-Orthomed, a leader in the animal health technology space .” said Justin Barad MD, CEO and co-founder of Osso VR.

Osso VR’s platform boasts an exceptional level of visual fidelity, ensuring every aspect of surgery, from anatomical detail to the OR environment, enhances the training experience.  In addition, the technology is proven to significantly impact surgical performance.  In two recent level 1 randomized peer-reviewed studies, surgeons training with Osso VR showed anywhere from a 230 percent to 306 percent improvement in overall surgical performance compared to traditional training. In addition, Osso VR enables healthcare professionals, including veterinarians, to  train together in VR from anywhere in the world through Remote Collaboration.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version